--- title: "Sichuan Shuangma's subsidiary Hubei Jianxiang passes on-site inspection by the US FDA" type: "News" locale: "en" url: "https://longbridge.com/en/news/243225316.md" description: "According to the announcement from Sichuan Shuangma, the company's holding subsidiary Hubei Jianxiang Biopharmaceutical Co., Ltd. (referred to as \"Hubei Jianxiang\") has received an on-site inspection report issued by the U.S. FDA. According to this inspection report, Hubei Jianxiang's quality and production systems meet the standards of the U.S. FDA and have passed the on-site inspection" datetime: "2025-06-05T08:05:04.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/243225316.md) - [en](https://longbridge.com/en/news/243225316.md) - [zh-HK](https://longbridge.com/zh-HK/news/243225316.md) generator: "portal-rs" --- # Sichuan Shuangma's subsidiary Hubei Jianxiang passes on-site inspection by the US FDA According to the announcement from Zhitong Finance APP, Sichuan Shuangma (000935.SZ) stated that its holding subsidiary Hubei Jianxiang Biopharmaceutical Co., Ltd. (referred to as "Hubei Jianxiang") has received an on-site inspection report issued by the U.S. FDA. According to this inspection report, Hubei Jianxiang's quality and production systems meet the standards of the U.S. FDA and passed the on-site inspection ### Related Stocks - [000935.CN](https://longbridge.com/en/quote/000935.CN.md) ## Related News & Research - [Money Managers Turn Bullish On China Despite Mounting Economic Woes](https://longbridge.com/en/news/296554795.md) - [MINEST: Record-breaking production and improved financials support global tidal energy expansion](https://longbridge.com/en/news/296446821.md) - [US Plains HRW Wheat-Basis flat to up with limited trade](https://longbridge.com/en/news/296655424.md) - [Petronas Chemicals reports higher revenue and profit but flags challenging outlook for the year](https://longbridge.com/en/news/296307726.md) - [FLU: Profit and EBITDA up on Malta growth and cost cuts, with 2026 guidance raised](https://longbridge.com/en/news/296306424.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**